Home / Publications / Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors

Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors

Sergey Zurabovich Vatsadze 1
Sergey Zurabovich Vatsadze
Yulia Dmitrievna Loginova 1
Yulia Dmitrievna Loginova
Irina Anatol'evna Vatsadze 2
Irina Anatol'evna Vatsadze
Li Wang 3
Li Wang
Haojie Yu 3
Haojie Yu
Konstantin Victorovich Kudryavtsev
Published 2016-04-28
CommunicationVolume 26, Issue 3, 212-213
10
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Vatsadze S. Z. et al. Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors // Mendeleev Communications. 2016. Vol. 26. No. 3. pp. 212-213.
GOST all authors (up to 50) Copy
Vatsadze S. Z., Shulga D. A., Loginova Y. D., Vatsadze I. A., Wang L., Yu H., Kudryavtsev K. V. Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors // Mendeleev Communications. 2016. Vol. 26. No. 3. pp. 212-213.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2016.04.011
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2016.04.011
TI - Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors
T2 - Mendeleev Communications
AU - Vatsadze, Sergey Zurabovich
AU - Shulga, Dmitry Alexandrovich
AU - Loginova, Yulia Dmitrievna
AU - Vatsadze, Irina Anatol'evna
AU - Wang, Li
AU - Yu, Haojie
AU - Kudryavtsev, Konstantin Victorovich
PY - 2016
DA - 2016/04/28
PB - Mendeleev Communications
SP - 212-213
IS - 3
VL - 26
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2016_Vatsadze,
author = {Sergey Zurabovich Vatsadze and Dmitry Alexandrovich Shulga and Yulia Dmitrievna Loginova and Irina Anatol'evna Vatsadze and Li Wang and Haojie Yu and Konstantin Victorovich Kudryavtsev},
title = {Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors},
journal = {Mendeleev Communications},
year = {2016},
volume = {26},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2016.04.011},
number = {3},
pages = {212--213},
doi = {10.1016/j.mencom.2016.04.011}
}
MLA
Cite this
MLA Copy
Vatsadze, Sergey Zurabovich, et al. “Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors.” Mendeleev Communications, vol. 26, no. 3, Apr. 2016, pp. 212-213. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2016.04.011.

Abstract

The docking study of ferrocene-substituted bispidines to binding sites of thrombin and factor Xa has shown that bispidine scaffold provides a 3D-arranegment of all substituents and a direction for the ferrocene group to fill the S4 pocket for both thrombin and factor Xa.

References

1.
Development of new methods in modern selective organic synthesis: Preparation of functionalized molecules with atomic precision
Ananikov V.P., Khemchyan L.L., Ivanova Y.V., Bukhtiyarov V.I., Sorokin A.M., Prosvirin I.P., Vatsadze S.Z., Medved'ko A.V., Nuriev V.N., Dilman A.D., Levin V.V., Koptyug I.V., Kovtunov K.V., Zhivonitko V.V., Likholobov V.A., et. al.
Russian Chemical Reviews, 2014
2.
Ananikov V.P., Khokhlova E.A., Egorov M.P., Sakharov A.M., Zlotin S.G., Kucherov A.V., Kustov L.M., Gening M.L., Nifantiev N.E.
Mendeleev Communications, 2015
3.
From in silico target prediction to multi-target drug design: current databases, methods and applications.
Koutsoukas A., Simms B., Kirchmair J., Bond P.J., Whitmore A.V., Zimmer S., Young M.P., Jenkins J.L., Glick M., Glen R.C., Bender A.
Journal of Proteomics, 2011
4.
The anticoagulants market
Melnikova I.
Nature Reviews Drug Discovery, 2009
5.
Oral, direct thrombin and factor Xa inhibitors: the replacement for warfarin, leeches, and pig intestines?
6.
Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies
Dubar F., Wintjens R., Martins-Duarte É.S., Vommaro R.C., de Souza W., Dive D., Pierrot C., Pradines B., Wohlkonig A., Khalife J., Biot C.
MedChemComm, 2011
7.
Synthesis, chemical characterization, DNA binding and antioxidant studies of ferrocene incorporated selenoure
Hussain R.A., Badshah A., Sohail M., Lal B., Akbar K.
Journal of Molecular Structure, 2013
8.
Synthesis of novel bridged dinitrogen heterocycles and their evaluation as potential fragments for the design of biologically active compounds
Kudryavtsev K.V., Shulga D.A., Chupakhin V.I., Sinauridze E.I., Ataullakhanov F.I., Vatsadze S.Z.
Tetrahedron, 2014
9.
Halogen bonding and other σ-hole interactions: a perspective
Politzer P., Murray J.S., Clark T.
Physical Chemistry Chemical Physics, 2013
10.
A Medicinal Chemist’s Guide to Molecular Interactions
Bissantz C., Kuhn B., Stahl M.
Journal of Medicinal Chemistry, 2010
12.
https://www.pymol.org/.
13.
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J.
Journal of Computational Chemistry, 2009
15.
https://www.chemaxon.com/products/marvin/marvinsketch.
16.
Open Babel: An open chemical toolbox
O'Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R.
Journal of Cheminformatics, 2011
17.
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R.
Journal of Cheminformatics, 2012
18.
Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B., Muley L., Heine A., Smolinski M., Hangauer D., Klebe G.
Journal of Molecular Biology, 2009
20.
Ligand efficiency and fragment-based drug discovery
Bembenek S.D., Tounge B.A., Reynolds C.H.
Drug Discovery Today, 2009